Supply of HIV drugs for children hit
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Despite having run out of child-friendly HIV drugs, the Indian drug controller’s Subject Expert Committee (SEC) has rejected fast track registration of the Lopinavir and Ritonavir pellets. The drugs are currently not registered in India and therefore, not available in the national HIV Programme. Meanwhile, the National AIDS Control Organisation (NACO) programme is running out of the substitute for oral pellets currently available in India — Lopinavir syrup.

India had run out of paediatric formulations of the syrup after Cipla Pharmaceutical, Lopinavir syrup’s sole manufacturer, stopped production over non-payment of dues. NACO had placed an emergency order for Lopinavir and written to the Drugs Controller General, requesting that Lopinavir and Ritonavir be registered soon. However, the fast track registeration of these drugs was rejected. This has left hapless parents to break up adult tablets and administer them to children. This has raised serious questions about dosages.

http://www.thehindu.com/sci-tech/health/supply-of-hiv-drugs-for-children-hit/article18418505.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
Preview
Like
Comment
Share